Department of Nutrition, Exercise and Sports
Copenhagen, Frederiksberg, 1958, Denmark
NCT Number: NCT02116829
The aim of this study is to examine the effects in humans of a moderate butter intake on risk markers of cardiovascular disease compared to a diet with the same amount of olive oil (refined and therefore without polyfenols).
The primary parameters are total cholesterol, LDL- and HDL cholesterol and triglycerides. The secondary parameters are risk markers of diabetes type 2; plasma glucose and insuling as well as the inflammatory marker hs-CRP.
Looking for future studies?
Notify Me20 year–70 year
All sexes
Interventional
Not applicable
Copenhagen, Frederiksberg, 1958, Denmark
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The effect of butter intake versus olive oil (refined) intake on blood lipids (primarily)
Other names: butter, diary
Time frame: 5 weeks
Time frame: 5 weeks
Time frame: 5 weeks
Time frame: 5 weeks
Time frame: 5 weeks
Time frame: 5 weeks
Time frame: 5 weeks
University of Copenhagen
Other
Is There Room for Butter in a Healthy Diet? - A Randomized Controlled Dietary Human Intervention
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05906797
Arterial Occlusive Diseases, Arteriosclerosis
Catania, Italy
View Trial DetailsNCT02991703
Arterial Occlusive Diseases, Arteriosclerosis
Nantes, France
View Trial DetailsNCT04167761
Arterial Occlusive Diseases, Arteriosclerosis
Stanford, California, United States
View Trial DetailsNCT02505399
Arterial Occlusive Diseases, Arteriosclerosis
Toulouse, Haute-Garonne, France
View Trial Details